| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO
1 company
Bernard Coulie is President and CEO at PLRX. From April 2020 to January 2026, the filings on record show 0 open-market purchases and 22 sales. Bernard Coulie's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $435K at current prices.
Our model assigns Bernard Coulie a strong insider score of 80/100, based on 28 past trades. Over a 12-month horizon, all 27 of those trades were profitable, with an average 12-month return of +43.1%.
The PLRX filings lean toward selling, a net 650,926 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 14, 2021 | PLRX Pliant Therapeutics, Inc. | President and CEO | Sell | 3,500 | $26.38 | $92,325.23 | -0.7% | |
| Dec 14, 2020 | PLRX Pliant Therapeutics, Inc. | President and CEO | Sell | 3,500 | $27.37 | $95,790.16 | -0.7% |